Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 7.45 USD 0.27% Market Closed
Market Cap: 516.8m USD

Wall Street
Price Targets

BCYC Price Targets Summary
Bicycle Therapeutics PLC

Wall Street analysts forecast BCYC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BCYC is 22.01 USD with a low forecast of 6.06 USD and a high forecast of 46.2 USD.

Lowest
Price Target
6.06 USD
19% Downside
Average
Price Target
22.01 USD
196% Upside
Highest
Price Target
46.2 USD
520% Upside
Bicycle Therapeutics PLC Competitors:
Price Targets
XFOR
X4 Pharmaceuticals Inc
109% Upside
301080
Acrobiosystems Co Ltd
39% Upside
BNTX
BioNTech SE
47% Upside
ALNY
Alnylam Pharmaceuticals Inc
25% Upside
ARGX
argenx SE
12% Upside
300122
Chongqing Zhifei Biological Products Co Ltd
32% Upside
IPH
Innate Pharma SA
206% Upside
ZYME
Zymeworks Inc
38% Upside

Revenue
Forecast

Revenue Estimate
Bicycle Therapeutics PLC

For the last 7 years the compound annual growth rate for Bicycle Therapeutics PLC's revenue is 50%. The projected CAGR for the next 4 years is 52%.

50%
Past Growth
52%
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Bicycle Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Bicycle Therapeutics PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-62%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BCYC's stock price target?
Price Target
22.01 USD

According to Wall Street analysts, the average 1-year price target for BCYC is 22.01 USD with a low forecast of 6.06 USD and a high forecast of 46.2 USD.

What is Bicycle Therapeutics PLC's Revenue forecast?
Projected CAGR
52%

For the last 7 years the compound annual growth rate for Bicycle Therapeutics PLC's revenue is 50%. The projected CAGR for the next 4 years is 52%.

Back to Top